tiprankstipranks
Trending News
More News >
Neuren Pharmaceuticals Limited (NURPF)
OTHER OTC:NURPF
US Market

Neuren Pharmaceuticals Limited (NURPF) Income Statement

Compare
54 Followers

Neuren Pharmaceuticals Limited Income Statement

Last quarter (Q2 2025), Neuren Pharmaceuticals Limited's total revenue was AU$28.28M, a decrease of -55.06% from the same quarter last year. In Q2, Neuren Pharmaceuticals Limited's net income was AU$15.03M. See Neuren Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
AU$ 213.24MAU$ 231.93MAU$ 14.55MAU$ 3.20MAU$ 717.00K
Gross Profit
AU$ 213.22MAU$ 205.17MAU$ 14.54MAU$ 3.19MAU$ 711.00K
Operating Expenses
AU$ 37.67MAU$ 32.70MAU$ 16.14MAU$ 11.42MAU$ 9.52M
Depreciation and Amortization
AU$ 22.00KAU$ 17.00KAU$ 10.00KAU$ 8.00KAU$ 6.00K
EBITDA
AU$ 175.57MAU$ 199.26MAU$ -670.00KAU$ -10.98MAU$ -9.90M
Operating Income
AU$ 175.55MAU$ 172.49MAU$ -1.60MAU$ -11.43MAU$ -9.53M
Other Income/Expenses
AU$ 7.39MAU$ 32.65MAU$ 916.00KAU$ 439.00KAU$ -384.00K
Pretax Income
AU$ 182.94MAU$ 205.14MAU$ -680.00KAU$ -10.99MAU$ -9.91M
Net Income
AU$ 142.04MAU$ 157.08MAU$ 184.00KAU$ -7.79MAU$ -9.19M
Per Share Metrics
Basic EPS
AU$ 1.09AU$ 1.24AU$ 0.00AU$ -0.07AU$ -0.09
Diluted EPS
AU$ 1.09AU$ 1.20AU$ 0.00AU$ -0.07AU$ -0.09
Weighted Average Shares Outstanding
127.77M 127.07M 125.97M 117.77M 107.06M
Weighted Average Shares Outstanding (Diluted)
130.78M 130.77M 128.91M 117.77M 107.06M
Currency in AUD

Neuren Pharmaceuticals Limited Earnings and Revenue History